US › Healthcare

AEON Biopharma, Inc. (AEON)

US · Healthcare · Biotechnology

$0.30+0.34%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

Net profit

$-11.8M

Profit YoY

-229.7%

EPS

$-0.25

EPS estimate

$-0.44

EPS came in at -0.25 against a street estimate of -0.44 — a beat of 43.2%.

Key statistics

Market cap

$12.9M

Forward P/E

1.2

P/B

0.00

Book value

$-0.66

EPS (TTM)

$-6.52

52-week high

$1.45

52-week low

$0.22

50-day MA

$0.58

200-day MA

$0.90

Beta

0.61

Analyst view

Analysts rate AEON Biopharma, Inc. a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $6.70.

Shareholding

Insiders

41.29%

Institutions

9.08%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for AEON Biopharma, Inc. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.